DR. BARRY EISENSTEIN
Chief Medical Officer
Barry Eisenstein received his MD from Columbia University followed by training in Internal Medicine and Infectious Diseases at the University of North Carolina. He has spent his career in academia and industry, serving as Professor and Chair of the Department of Microbiology and Immunology at the University of Michigan, Vice President of Infectious Diseases Discovery and Clinical Development at Eli Lilly, Professor of Medicine at Harvard Medical School, and Senior Vice President of Scientific Affairs at Cubist (acquired in 2015 by Merck). He has edited several books on infectious diseases and microbiology, and was a past editor of both Infection and Immunity (1989-96) and Antimicrobial Agents and Chemotherapy (2004-14).